Division of Allergy and Clinical Immunology, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
Division of Allergy and Clinical Immunology, Department of Pediatrics, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada.
Ann Allergy Asthma Immunol. 2022 Sep;129(3):342-346. doi: 10.1016/j.anai.2022.06.005. Epub 2022 Jun 10.
Sesame can cause severe allergic reactions and is a priority allergen in Canada.
To assess clinical characteristics and management of pediatric sesame-induced anaphylaxis and identify factors associated with epinephrine treatment.
Between 2011 and 2021, children with sesame-induced anaphylaxis presenting to 7 emergency departments (ED) in 4 Canadian provinces and 1 regional emergency medical service were enrolled in the Cross-Canada Anaphylaxis Registry. Standardized recruitment forms provided data on symptoms, severity, triggers, and management. Multivariate logistic regression evaluated associations with epinephrine treatment pre-ED and multiple epinephrine dosages.
Of all food-induced anaphylactic reactions (n = 3279 children), sesame accounted for 4.0% (n = 130 children), of which 61.5% were boys, and the average (SD) age was 5.0 (4.9) years. Hummus containing sesame paste triggered 58.8% of reactions. In the pre-ED setting, 32.3% received epinephrine, and it was more likely to be used in boys (adjusted odds ratio [aOR], 1.27; 95% confidence interval [CI], 1.08-1.50) and those with a known food allergy (aOR, 1.36; 95% CI, 1.11-1.68]). In the ED, 47.7% of cases received epinephrine, with older children more likely to receive multiple epinephrine doses (aOR, 1.00; 95% CI, 1.00-1.02).
In Canada, hummus is the major trigger of sesame-induced anaphylaxis. Knowledge translation focused on prompt epinephrine use and product-labeling policies are required to limit sesame reactions in communities.
芝麻可引起严重过敏反应,是加拿大的首要过敏原。
评估儿科芝麻诱发过敏反应的临床特征和管理方法,并确定与肾上腺素治疗相关的因素。
2011 年至 2021 年间,加拿大 4 个省和 1 个地区的 7 个急诊部(ED)和 1 个区域紧急医疗服务机构纳入了芝麻诱发过敏反应的跨加过敏反应登记处,招募患有芝麻诱发过敏反应的儿童。标准化招募表提供了症状、严重程度、诱因和管理方面的数据。多变量逻辑回归评估了 ED 前和多次肾上腺素剂量与肾上腺素治疗的相关性。
在所有食物诱发的过敏反应(n=3279 例儿童)中,芝麻占 4.0%(n=130 例儿童),其中 61.5%为男孩,平均(SD)年龄为 5.0(4.9)岁。芝麻糊引起 58.8%的反应。在 ED 前环境中,32.3%的患者接受了肾上腺素治疗,男孩(调整后的优势比 [aOR],1.27;95%置信区间 [CI],1.08-1.50)和已知食物过敏(aOR,1.36;95% CI,1.11-1.68)的患者更有可能使用肾上腺素。在 ED,47.7%的病例接受了肾上腺素治疗,年龄较大的儿童更有可能接受多次肾上腺素剂量(aOR,1.00;95% CI,1.00-1.02)。
在加拿大,芝麻糊是芝麻诱发过敏反应的主要诱因。需要进行知识转化,重点关注及时使用肾上腺素和产品标签政策,以限制社区中芝麻反应的发生。